The dermatology company agreed to acquire ZO Skin Health from its shareholders, including the Obagi family and funds managed by Blackstone Tactical Opportunities.
Galderma to Buy ZO Skin Health for $1.5 Billion
The dermatology company agreed to acquire ZO Skin Health from its shareholders, including the Obagi family and funds managed by Blackstone Tactical Opportunities.
Sign in to your account